United Therapeutics Corp. (U2TH34)
Market Closed
7 Aug, 19:55
B3 B3 Primary R$
130. 00
0
0%
R$
59.53B Market Cap
11.96 P/E Ratio
- Div Yield
2 Volume
24.04 Eps
R$ 130
Previous Close Want to track U2TH34 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
U2TH34 Earnings Reports FAQ
What is the earnings per share (EPS) for U2TH34?
The current EPS is 24.04.
What is the company's earnings growth rate?
United Therapeutics Corp has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
United Therapeutics Corp has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for United Therapeutics Corp are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for U2TH34 at this time, as United Therapeutics Corp has no recent EPS data to calculate it.
